GA
NTUS

Geneva Advisors’s Natus Medical Inc NTUS Stock Holding History

Geneva Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,076
Closed -$838K – 825
2016
Q4 		$838K Sell
24,076
-4,149
-15% -$163K 0.02% 382
2016
Q3 		$1.11M Buy
28,225
+262
+0.9% +$10.4K 0.02% 294
2016
Q2 		$1.06M Buy
27,963
+14,287
+104% +$478K 0.02% 302
2016
Q1 		$526K Buy
+13,676
New +$509K 0.01% 421

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geneva Advisors's NTUS Position: Q1 2017 in Review

Geneva Advisors sold out of Natus Medical Inc (NTUS) in Q1 2017, closing a stake of 24,076 shares — an estimated $838K sold.

Geneva Advisors first reported a position in NTUS in Q1 2016 and held it in 4 quarters. The position peaked at $1.11M in Q3 2016. 212 funds tracked by Wall St. Rank hold NTUS as of Q1 2017.

  • Geneva Advisors reported no remaining Natus Medical Inc position as of Q1 2017 after selling out during the quarter.
  • Geneva Advisors sold 24,076 Natus Medical Inc shares in Q1 2017, an estimated $838K.
  • Geneva Advisors first reported a position in Natus Medical Inc in Q1 2016 and held it in 4 quarters.
  • Geneva Advisors's Natus Medical Inc position peaked at $1.11M in Q3 2016.
  • 212 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2017.

Based on Geneva Advisors's 13F filing for Q1 2017, filed 1 May 2017.